Skip to main content
Abnova logo

Abnova — Investor Relations & Filings

Ticker · 4133 ISIN · TW0004133004 TW Professional, scientific and technical activities
Open in API
Filings indexed 1,483 across all filing types
Latest filing 2015-08-05 Share Issue/Capital Cha…
Country TW Taiwan
Listing TW 4133

About Abnova

http://www.abnova.com

Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.

Recent filings

Filing Released Lang Actions
104年8月變更登記
Share Issue/Capital Change Classification · 95% confidence The document contains detailed information about the company's capital structure, including authorized capital, paid-in capital, capital increases, capital reductions, and cancellation of treasury shares. It is a formal disclosure of capital changes rather than a full financial report or announcement of a meeting or vote. The document length is short (817 characters), but it is not merely an announcement of a report publication. It specifically details capital changes and share capital information, which fits the category of Share Issue/Capital Change filings.
2015-08-05 Chinese
104年08月僑外投資持股
Major Shareholding Notification Classification · 95% confidence The document is a statistical table showing the shareholding situation of overseas and mainland China investors, including changes due to capital reduction and detailed shareholding numbers. It includes specific dates and share counts but does not contain financial statements, management discussion, or report narratives. The document is short (1064 characters) and is a regulatory disclosure of shareholding changes rather than a full report or announcement of a meeting or vote. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is best classified as a Major Shareholding Notification (MRQ) because it reports on changes in significant share ownership levels and related shareholding statistics.
2015-08-05 Chinese
103年年報及股東會資料 — 2014_4133_20150623F11.pdf
Regulatory Filings
2015-07-20 Chinese
103年年報及股東會資料 — 2015_4133_20150623F05.pdf
Annual Report Classification · 95% confidence The document is a detailed record of the Annual General Meeting (AGM) of 亞諾法生技股份有限公司 for the fiscal year 104 (2015), including attendance, agenda items, and resolutions passed. It contains the 103 fiscal year (2014) operational report, financial statements, auditor's report, and supervisory review report. The presence of comprehensive financial data such as balance sheets, income statements, cash flow statements, and notes to the financial statements indicates this is a full annual report. The document also includes management discussion of business operations and future plans, typical of an Annual Report (10-K). The length (15,000 characters) and detailed financial disclosures confirm it is not merely an announcement or certification. Therefore, the document is classified as an Annual Report (10-K).
2015-07-20 Chinese
103年年報及股東會資料 — 2015_4133_20150623F15.pdf
Capital/Financing Update Classification · 95% confidence The document is a detailed procedural manual titled '資金貸與及背書保證作業程序' which translates to 'Procedures for Fund Lending and Endorsement Guarantees'. It outlines the company's internal policies, scope, implementation, approval processes, risk assessments, limits, internal controls, and reporting requirements related to lending funds and providing guarantees or endorsements. There is no indication that this is a financial report, earnings release, or regulatory filing announcement. Instead, it is a governance document detailing internal operational procedures and controls related to capital and financing activities. Given the content focuses on procedures and governance around capital lending and guarantees, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a regulatory filing. Confidence is high due to the clear procedural nature and focus on capital operations.
2015-07-20 Chinese
103年年報及股東會資料 — 2015_4133_20150623F14.pdf
Governance Information Classification · 95% confidence The document is a detailed procedural manual titled '取得或處分資產處理程序' (Procedures for Acquisition or Disposal of Assets) for a company, referencing the Securities Exchange Act and specific regulations related to acquisition or disposal of assets by publicly listed companies. It includes detailed internal control procedures, authorization limits, valuation requirements, board and independent director involvement, disclosure and reporting obligations, and risk management for various asset types including real estate, securities, intangible assets, derivatives, and related party transactions. The document is regulatory and governance-focused, outlining compliance with asset transaction rules rather than presenting financial results or audit opinions. It does not contain financial statements, earnings data, or audit reports. It is not an announcement or a brief notice but a comprehensive procedural document. This fits best under Governance Information (CGR), which covers reports detailing internal rules, board structure, and governance practices, including compliance procedures for asset transactions.
2015-07-20 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.